{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T09:22:12Z","timestamp":1787822532851,"version":"build-2784847793"},"reference-count":46,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"VAMC-CT"},{"name":"Fred Kunnes Fund"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>C-C chemokine receptor type 5 (CCR5) is the primary co-receptor mediating the entry of R5-tropic human immunodeficiency virus type 1 (HIV-1) into CD4+ T cells and macrophages, making it one of the most promising therapeutic targets in HIV cure research. The naturally occurring CCR5\u039432 mutation which abolishes surface CCR5 expression in homozygous individuals has provided strong clinical evidence for CCR5-directed strategies after multiple cases of sustained HIV remission following allogeneic hematopoietic stem cell transplantation (HSCT) from CCR5\u039432 donors. This review summarizes the current understanding of the evolutionary origin and global distribution of the CCR5\u039432 allele, as well as the clinical evidence from landmark transplantation cases. We also discuss recent findings demonstrating that durable HIV remission may be achieved following transplantation from heterozygous CCR5 wild-type\/\u039432 donors, suggesting that factors such as donor chimerism, conditioning regimens and graft-versus-reservoir effects contribute substantially to reservoir clearance alongside CCR5 disruption. In addition, we examine emerging evidence that pharmacological inhibition of the Janus kinase\/signal transducer and activator of transcription (JAK\/STAT) pathway can reversibly suppress CCR5 expression, reduce HIV replication, limit reservoir establishment, and attenuate immune activation. Collectively, these advances highlight the evolving landscape of CCR5-targeted therapies and support the development of safer and more broadly applicable approaches toward durable HIV remission and, ultimately, an HIV cure.<\/jats:p>","DOI":"10.3390\/v18090933","type":"journal-article","created":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T09:00:35Z","timestamp":1787821235000},"page":"933","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Emerging CCR5-Based Therapeutic Potential of JAK\/STAT Inhibitors and CCR5\u039432 Hematopoietic Stem Cell Transplantation"],"prefix":"10.3390","volume":"18","author":[{"given":"Khadija","family":"Khalid","sequence":"first","affiliation":[{"name":"Section of Infectious Diseases, Department of Medicine, Yale School of Medicine, New Haven, CT 06520, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-2341-0974","authenticated-orcid":false,"given":"Uzair","family":"Iqbal","sequence":"additional","affiliation":[{"name":"Section of Infectious Diseases, Department of Medicine, Yale School of Medicine, New Haven, CT 06520, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8253-530X","authenticated-orcid":false,"given":"Mohamed","family":"Shaltout","sequence":"additional","affiliation":[{"name":"Section of Infectious Diseases, Department of Medicine, Yale School of Medicine, New Haven, CT 06520, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunus","family":"Yukselten","sequence":"additional","affiliation":[{"name":"Section of Infectious Diseases, Department of Medicine, Yale School of Medicine, New Haven, CT 06520, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farooq","family":"Ahmad","sequence":"additional","affiliation":[{"name":"Section of Infectious Diseases, Department of Medicine, Yale School of Medicine, New Haven, CT 06520, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdur Rehman","family":"Khalid","sequence":"additional","affiliation":[{"name":"Section of Infectious Diseases, Department of Medicine, Yale School of Medicine, New Haven, CT 06520, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard E.","family":"Sutton","sequence":"additional","affiliation":[{"name":"Section of Infectious Diseases, Department of Medicine, Yale School of Medicine, New Haven, CT 06520, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/s11033-026-11586-4","article-title":"From bench to bedside: Stem cell therapy as a transformative approach against HIV","volume":"53","author":"S","year":"2026","journal-title":"Mol. Biol. Rep."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"eadl0368","DOI":"10.1126\/sciadv.adl0368","article-title":"JAK\/STAT signaling pathway affects CCR5 expression in human CD4+ T cells","volume":"10","author":"Wang","year":"2024","journal-title":"Sci. Adv."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"110375","DOI":"10.1016\/j.virol.2024.110375","article-title":"Targeting CCR5: A central approach to HIV treatment and cure strategies","volume":"603","author":"Yukselten","year":"2025","journal-title":"Virology"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Jasinska, A.J., Pandrea, I., and Apetrei, C. (2022). CCR5 as a Coreceptor for Human Immunodeficiency Virus and Simian Immunodeficiency Viruses: A Prototypic Love-Hate Affair. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.835994"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.coviro.2015.06.007","article-title":"CCR5\u039432 mutation and HIV infection: Basis for curative HIV therapy","volume":"14","author":"Allers","year":"2015","journal-title":"Curr. Opin. Virol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e2321907121","DOI":"10.1073\/pnas.2321907121","article-title":"Legacy of a magic gene-CCR5-\u2206 32: From discovery to clinical benefit in a generation","volume":"121","author":"Obrien","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41591-023-02213-x","article-title":"In-depth virological and immunological characterization of HIV-1 cure after CCR5\u039432\/\u039432 allogeneic hematopoietic stem cell transplantation","volume":"29","author":"Jensen","year":"2023","journal-title":"Nat. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.cell.2023.02.030","article-title":"HIV-1 remission and possible cure in a woman after haplo-cord blood transplant","volume":"186","author":"Hsu","year":"2023","journal-title":"Cell"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1038\/s41564-026-02304-8","article-title":"Long-term HIV-1 remission achieved through allogeneic haematopoietic stem cell transplant from a CCR5\u039432\/\u039432 sibling donor","volume":"11","author":"Myhre","year":"2026","journal-title":"Nat. Microbiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/s41586-019-1027-4","article-title":"HIV-1 remission following CCR5\u039432\/\u039432 haematopoietic stem-cell transplantation","volume":"568","author":"Gupta","year":"2019","journal-title":"Nature"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e389","DOI":"10.1016\/S2352-3018(24)00090-0","article-title":"Dynamics of virological and immunological markers of HIV persistence after allogeneic hematopoietic stem cell transplantation in the IciStem Cohort: A prospective observational cohort analysis","volume":"11","author":"Salgado","year":"2024","journal-title":"Lancet HIV"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"674","DOI":"10.7326\/M18-0759","article-title":"Mechanisms That Contribute to a Profound Reduction of the HIV-1 Reservoir After Allogeneic Stem Cell Transplant","volume":"169","author":"Salgado","year":"2018","journal-title":"Ann. Intern. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/s41586-025-09893-0","article-title":"Sustained HIV-1 remission after heterozygous CCR5\u039432 stem cell transplantation","volume":"650","author":"Gaebler","year":"2026","journal-title":"Nature"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Clees, J., Basic, M., Cruz, P.E., Ramirez, S.H., and Andrews, A.M. (2025). In pursuit of an HIV cure: From stem cell transplants to gene therapies. Front. Genome Ed., 7.","DOI":"10.3389\/fgeed.2025.1634193"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1128\/AAC.02496-13","article-title":"Ruxolitinib and Tofacitinib Are Potent and Selective Inhibitors of HIV-1 Replication and Virus Reactivation In Vitro","volume":"58","author":"Gavegnano","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Gavegnano, C., Brehm, J.H., Dupuy, F.P., Talla, A., Ribeiro, S.P., A Kulpa, D., Cameron, C., Santos, S., Hurwitz, S.J., and Marconi, V.C. (2017). Novel mechanisms to inhibit HIV reservoir seeding using Jak inhibitors. PLoS Pathog., 13.","DOI":"10.1371\/journal.ppat.1006740"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"de Armas, L.R., Gavegnano, C., Pallikkuth, S., Rinaldi, S., Pan, L., Battivelli, E., Verdin, E., Younis, R.T., Pahwa, R., and Williams, S.L. (2021). The Effect of JAK1\/2 Inhibitors on HIV Reservoir Using Primary Lymphoid Cell Model of HIV Latency. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.720697"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1002\/jmv.25658","article-title":"Evaluation of CCR5-\u039432 mutation among individuals with high risk behaviors, neonates born to HIV-1 infected mothers, HIV-1 infected individuals, and healthy people in an Iranian population","volume":"92","author":"Donyavi","year":"2020","journal-title":"J. Med. Virol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"8823863","DOI":"10.1155\/2023\/8823863","article-title":"Prevalence of CCR5 Delta 32 Genetic Variant in the Turkmen Population of Golestan Province, Northeast of Iran","volume":"2023","author":"Norasi","year":"2023","journal-title":"BioMed Res. Int."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e70591","DOI":"10.1002\/jmv.70591","article-title":"Frequency of the CCR5\u039432 Variant in Haematopoietic Progenitor Cell Donors From Argentina: Implications for Transplantation in HIV-1 Infected Patients","volume":"97","author":"Galarza","year":"2025","journal-title":"J. Med. Virol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.1016\/j.cell.2025.04.015","article-title":"Tracing the evolutionary history of the CCR5delta32 deletion via ancient and modern genomes","volume":"188","author":"Ravn","year":"2025","journal-title":"Cell"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJMc2312556","article-title":"HIV-1 Remission after Allogeneic Hematopoietic-Cell Transplantation","volume":"390","author":"Dickter","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e652","DOI":"10.1016\/S2352-3018(20)30117-X","article-title":"Hematopoietic Cell Transplantation in HIV patients","volume":"7","author":"Ambinder","year":"2020","journal-title":"Lancet HIV"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S1473-3099(10)70319-4","article-title":"European guidelines on the clinical management of HIV-1 tropism testing","volume":"11","author":"Vandekerckhove","year":"2011","journal-title":"Lancet Infect. Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"15866","DOI":"10.1038\/s41598-020-71699-z","article-title":"Immune activation correlates with and predicts CXCR4 co-receptor tropism switch in HIV-1 infection","volume":"10","author":"Connell","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1080\/1040841X.2021.1902941","article-title":"HIV co-receptor-tropism: Cellular and molecular events behind the enigmatic co-receptor switching","volume":"47","author":"Yandrapally","year":"2021","journal-title":"Crit. Rev. Microbiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/JVI.00793-17","article-title":"Pace of Coreceptor Tropism Switch in HIV-1-Infected Individuals after Recent Infection","volume":"91","author":"Arif","year":"2017","journal-title":"J. Virol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1086\/507312","article-title":"Prevalence of CXCR4 tropism among antiretroviral-treated HIV-1-infected patients with detectable viremia","volume":"194","author":"Hunt","year":"2006","journal-title":"J. Infect. Dis."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Guerra-Castillo, F.X., Pinto-Cardoso, S., \u00c1vila-R\u00edos, S., Ch\u00e1vez-Torres, M., Peralta-Prado, A., Gonz\u00e1lez-Torres, C., Gayt\u00e1n-Cervantes, J., Requena-Benitez, B., D\u00edaz-Rivera, D., and Alaez-Verson, C. (2025). Patterns of inflammation and immune activation by coreceptor use in people living with HIV-1. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1632287"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1093\/cid\/ciy565","article-title":"Rapid Rebound of a Preexisting CXCR4-tropic Human Immunodeficiency Virus Variant After Allogeneic Transplantation with CCR5 \u039432 Homozygous Stem Cells","volume":"68","author":"Verheyen","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1056\/NEJMc1405805","article-title":"Shift of HIV tropism in stem-cell transplantation with CCR5 Delta32 mutation","volume":"371","author":"Kordelas","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Horberg, M., Thompson, M., Agwu, A., Colasanti, J., Haddad, M., Jain, M., McComsey, G., Radix, A., Rakhmanina, N., and Short, W.R. (2024). Primary Care Guidance for Providers of Care for Persons with Human Immunodeficiency Virus: 2024 Update by the HIV Medicine Association of the Infectious Diseases Society of America. Clin. Infect. Dis., ciae479.","DOI":"10.1093\/cid\/ciae479"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/phar.2914","article-title":"Consensus recommendations for the use of novel antiretrovirals in persons with HIV who are heavily treatment-experienced and\/or have multidrug-resistant HIV-1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy","volume":"44","author":"Cluck","year":"2024","journal-title":"Pharmacother. J. Hum. Pharmacol. Drug Ther."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e3572","DOI":"10.1093\/cid\/ciaa1391","article-title":"Primary Care Guidance for Persons with Human Immunodeficiency Virus: 2020 Update by the HIV Medicine Association of the Infectious Diseases Society of America","volume":"73","author":"Thompson","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Lewis, M., Mori, J., Toma, J., Mosley, M., Huang, W., Simpson, P., Mansfield, R., Craig, C., van der Ryst, E., and Robertson, D.L. (2018). Clonal analysis of HIV-1 genotype and function associated with virologic failure in treatment-experienced persons receiving maraviroc: Results from the MOTIVATE phase 3 randomized, placebo-controlled trials. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0204099"},{"key":"ref_36","first-page":"1628","article-title":"CCR5 deletion mutation and its association with the risk of developing acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation","volume":"91","author":"Duda","year":"2006","journal-title":"Haematologica"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"e13095","DOI":"10.1111\/ctr.13095","article-title":"The effect of CCR5\u039432 on the risk of grade 3-4 acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: A systematic review and meta-analysis","volume":"31","author":"Niu","year":"2017","journal-title":"Clin. Transplant."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1056\/NEJMra1202117","article-title":"JAKs and STATs in Immunity, Immunodeficiency, and Cancer","volume":"368","author":"Holland","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1089\/aid.1998.14.1509","article-title":"Functional Analysis of the Proximal CCR5 Promoter","volume":"14","author":"Liu","year":"1998","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1038\/onc.2011.79","article-title":"Serum\/glucocorticoid-regulated kinase 1 (SGK1) is a prominent target gene of the transcriptional response to cytokines in multiple myeloma and supports the growth of myeloma cells","volume":"30","author":"Fagerli","year":"2011","journal-title":"Oncogene"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1007\/s10753-023-01857-8","article-title":"Role of Serum\/Glucocorticoid-Regulated Kinase 1 (SGK1) in Immune and Inflammatory Diseases","volume":"46","author":"Bian","year":"2023","journal-title":"Inflammation"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/cid\/ciab212","article-title":"Randomized Trial of Ruxolitinib in Antiretroviral-Treated Adults With Human Immunodeficiency Virus","volume":"74","author":"Marconi","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"3544","DOI":"10.1038\/s41591-024-03277-z","article-title":"Sustained HIV remission after allogeneic hematopoietic stem cell transplantation with wild-type CCR5 donor cells","volume":"30","author":"Mamez","year":"2024","journal-title":"Nat. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"4801","DOI":"10.1158\/0008-5472.CAN-19-1167","article-title":"Recent Advances targeting CCR5 for Cancer and its Role in Immuno-Oncology","volume":"79","author":"Jiao","year":"2019","journal-title":"Cancer Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1056\/NEJMoa1201248","article-title":"Blockade of Lymphocyte Chemotaxis in Visceral Graft-versus-Host Disease","volume":"367","author":"Reshef","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Gavegnano, C., Savarino, A., Owanikoko, T., and Marconi, V.C. (2019). Crossroads of Cancer and HIV-1: Pathways to a Cure for HIV. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.02267"}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/18\/9\/933\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T09:02:10Z","timestamp":1787821330000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/18\/9\/933"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,27]]},"references-count":46,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["v18090933"],"URL":"https:\/\/doi.org\/10.3390\/v18090933","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,27]]}}}